Results 171 to 180 of about 33,747 (210)
Footprints of worldwide adaptation in structured populations ofD. melanogasterthrough the expanded DEST 2.0 genomic resource
Nunez JCB, Coronado-Zamora M, Gautier M, Kapun M, Steindl S, Ometto L, Hoedjes KM, Beets J, Wiberg RAW, Mazzeo GR, Bass DJ, Radionov D, Kozeretska I, Zinchenko M, Protsenko O, Serga S, Amor-Jimenez C, Casillas S, Sanchez-Gracia A, Patenkovic A, Glaser-Schmitt A, Barbadilla A, Buendia-Ruiz AJ, Bertelli AC, Kiss B, Önder BS, Matrín BR, Wertheim B, Deschamps C, Arboleda-Bustos CE, Tinedo C, Feller C, Schlötterer C, Lawler C, Fricke C, Vieira CP, Vieira C, Obbard DJ, Orengo D, Vela D, Amat E, Loreto E, Kerdaffrec E, Mitchell ED, Puerma E, Staubach F, Camus F, Colinet H, Hrcek J, Sørensen JG, Abbott J, Torro J, Parsch J, Vieira J, Olmo JL, Khfif K, Wojciechowski K, Madi-Ravazzi L, Kankare M, Schou MF, Ladoukakis M, Gomez-Julian MJ, Espinosa-Jimenez ML, Garcia Guerreiro MP, Parakatselaki M, Veselinovic MS, Tanaskovic M, Stamenkovic-Radak M, Paris M, Pascual M, Ritchie MG, Rera M, Jelić M, Ansari MH, Rakic M, Merenciano M, Hernandes N, Gora N, Rode N, Rota-Stabelli O, Sepulveda P, Gibert P, Carazo P, Kohlmeier P, Erickson PA, Vitalis R, Torres R, Guirao-Rico S, Ramos-Onsins SE, Castillo S, Paulo TF, Tyukmaeva V, Alonso Z, Alatortsev V, Pasyukova E, Mukha D, Petrov D, Schmidt P, Flatt T, Bergland AO, Gonzalez J. +100 moreeuropepmc +1 more sourceDapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial.
JAMATavares CAM, Azevedo LCP, Rea-Neto Á, Campos NS, Amendola CP, Kozesinski-Nakatani AC, David-João PG, Lobo SM, Filiponi TC, Almeida GMB, Bergo RR, Guimarães-Júnior MRR, Figueiredo RC, Castro JR, Schuler CJ, Westphal GA, Carioca ACR, Monfradini F, Nieri J, Neves FMO, Paulo JA, Albuquerque CSN, Silva MCR, Kosiborod MN, Pereira AJ, Damiani LP, Corrêa TD, Serpa-Neto A, Berwanger O, Zampieri FG, DEFENDER Investigators. +30 moreeuropepmc +1 more source
